It can feel frustrating when the NHS won’t accept private tests like mycotoxin panels, IgG food intolerance kits, or home mould testing. But this isn’t about being difficult — it’s about protecting patients and making sure care is fair, safe, and effective.
-
Safety first
Unvalidated tests can give false positives (saying you have a problem when you don’t) or false negatives (missing something important). Acting on the wrong result could lead to unnecessary medication, restrictive diets, or missed diagnoses. -
Evidence matters
NHS doctors can only use tests that have been proven in research to give accurate, meaningful results. That way, they can be confident the result will actually help guide treatment. -
Protecting patients from harm
Many private tests are expensive and may push people toward costly supplements, detox regimes, or antifungals they don’t need. The NHS avoids recommending anything that risks harm or waste. -
Fairness and trust
The NHS has to provide care that is fair for everyone. That means sticking to tests and treatments that have passed strict checks for accuracy, safety, and usefulness.
💙 Key message: When the NHS says “we can’t use that test,” it’s not about being awkward or dismissive — it’s about making sure that what’s offered is safe, reliable, and genuinely helps patients.
Private companies that sell mycotoxin or food intolerance tests will naturally try to justify their services — it’s their business, after all. But before you spend money, it’s worth asking one key question: ‘Will my NHS doctor be able to use these results to guide my treatment?’ If the answer is no (and in most cases it is), then you may just be spending a lot of money without getting anything useful for your care.
That doesn’t mean your symptoms aren’t real — it just means these particular tests aren’t the right tool. NHS doctors can only act on validated results (like CT scans, Aspergillus antibody blood tests, or sputum cultures) because those are proven to be accurate and safe.
Share this post
Latest News posts
Recent Aspergillosis Research – January 2026 (week 2)
January 16, 2026
Sinusitis in Patients with ABPA
January 16, 2026
Hydrocortisone dosing in adrenal insufficiency
January 5, 2026
Season’s Greeting
December 24, 2025
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
